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Galectins are a family of glycan-binding molecules with a characteristic affinity for ß-D-
glycosides that mediate a variety of important cellular functions, including immune and
inflammatory responses. Galectin-11 (LGALS-11) has been recently identified as a mediator
induced specifically in animals against gastrointestinal nematodes and can interfere with
parasite growth and development. Here, we report that at least two natural genetic variants
of LGALS-11 exist in sheep, and demonstrate fundamental differences in anti-parasitic activity,
correlated with their ability to dimerise. This study improves our understanding of the role of
galectins in the host immune and inflammatory responses against parasitic nematodes and
provides a basis for genetic studies toward selective breeding of animals for resistance to
parasites.
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Galectins are proteins that specifically bind to β-galactosidesugars. Currently, 15 galectins are recognised in mammalsand are encoded by LGALS genes. They include galectins-
1, -2, -3, -4, -7, -8, -9, -10 and -12 of humans, and galectins-5 and
-6 of rodents, and galectins-11, -14 and -15 of sheep and goats.
Galectins have been found also in other species of mammals, as
well as amphibians, birds, fish, nematodes, sponges and selected
fungi1. They are soluble proteins that function within or outside
of cells, and are present predominantly in the cytosol, nucleus,
and extracellular matrix or in lymph. Although some galectins are
secreted, they do not possess a classical (secretion) signal peptide,
and it is not yet known how these molecules are secreted1.
Mammalian galectins are known to mediate developmental
processes, including cell differentiation, tissue organisation2–4 and
regulate immune homoeostasis5,6. They modulate the recognition
and effector functions in innate immunity7, and bind glycans on
the surface of microorganisms and parasites8–14. Published evi-
dence9 shows that parasitic nematodes of the alimentary tract can
upregulate galectin expression in selected tissues in stomach, small
intestine and liver. In animals, for instance, nematode larvae
induce increased expression of galectin-11, which is produced by
epithelial cells and secreted into the gut lumen, coinciding with an
eosinophil-biased inflammatory response characteristically asso-
ciated with larval infection(s)9,15,16. As a functional analogue of
galectin-1, galectin-11 is proposed to cross-link glycans in mucus
to form a physical barrier against the parasite(s), as part of a
pronounced inflammatory response17,18. The exacerbated
expression of galectin-11 during challenge infection indicates that
this molecule is intimately involved in innate and adaptive
immune responses15.
Despite this knowledge, the molecular biology and function(s)
of galectin-11 are not understood. Gaining insights into the
structural biology of this galectin is central to beginning to
understand its function. In the present study, we explored the
structure of galectin-11 of sheep (Ovis aries), and assessed whe-
ther and how amino acid alterations in this galectin and asso-
ciated structural changes might affect its ability to interact with
Haemonchus contortus (order Strongylida)—a major eukaryotic
pathogen of the largest group of socioeconomically important
nematodes of vertebrates19. This study found that, the presence of
two genetic variants of LGALS-11 in sheep, and demonstrates
that the oligomeric property of this galectin is critical for its anti-
parasitic activity.
Results
Two isoforms of LGALS-11 detected in sheep. To explore
whether sequence variation in galectin-11 (designated LGALS-11)
occurs within O. aries, we sequenced this gene from 16 indivi-
duals (Merino breed) and deduced the amino acid sequences.
Two distinct isoforms (1 and 2) represented 9 and 7 sheep,
respectively (Fig. 1a). An alignment over 137 amino acids
revealed that the two LGALS-11 isoforms differed at 15 amino
acid positions (10.9%; Fig. 1a). We then explored the structure
and function of these isoforms.
Crystal structure of sheep LGALS-11. First, we solved the crystal
structure of LGALS-11 in apo form to 2.0 Å complexed with β-D-
galactose at 2.4 Å (Table 1). Both the apo form and the ligand-
bound crystals belongs to the space group of P212121, comprising
eight molecules in an asymmetric unit20, suggesting that LGALS-
11 can form higher order oligomers, like galectin-1 (refs. 21,22).
The LGALS-11 structure has two anti-parallel, six-stranded (S1,
8–12; S2, 34–41; S3, 50–58; S4 59–67; S5, 70–72; S6a, 75–79; S6,
121–128) and five-stranded (F1, 16–27; F2, 88–96; F3, 97–104; F4,
106–113; F6, 129–137) β-sheets23 with a typical galectin-fold
(Fig. 1b). The crystal structure of LGALS-11 has a folding pattern
that is similar to prototype galectins-1, -2 and -10, suggesting a
relatively conserved ligand-binding activity. LGALS-11 forms a
homodimer via hydrogen bonds between residues L9 and S11 of
monomers (i), and is inferred to have two unique cell attachment
sites (called LDV and RGD) for integrin binding (ii). The
asymmetric unit suggests that LGALS-11 can form higher order
oligomers, like galectin-1 (refs. 21,22).
Glycan recognition by LGALS-11. Complexing LGALS-11 with
β-D-galactose allowed us to identify residues critical for glycan
binding. This galactose bound directly to the residues present in
the four adjacent strands (S3, S4, S5 and S6) on the concave face
of one β-sheet (Fig. 1b). The glycan-binding groove expands from
residues 50–74 (β4–β8 strands), and the carbohydrate-
recognising residues (i.e., 54 R, 62 V, 64 N, 71W and 74 E)
within the carbohydrate recognition domain (CRD; Fig. 1c) are
conserved, as expected of mammalian galectins23.
In a structure-based alignment of these 16 LGALS-11
sequences, we identified a polymorphism at residue 9 (L/Q;
Fig. 1a), within the glycan-binding domain and cell attachment
domain. The glycan-binding domain (residues 53–74) of isoform
1 harboured highly hydrophobic residues (65–81; Fig. 2),
consistent with other known galectins1,24,25. Variability in the
glycan-binding groove (60 I/M, 65 T/A, 72 G/E and 75Q/E) of
isoform 2 related to differences in hydrophobicity and electro-
static potential in the CRD (Fig. 2), suggesting that this isoform
has a lower affinity for β-D-galactosides than isoform 1, and that
it can interact with distinct glycans.
Effect of sequence variation on quaternary structure. To test
the hypothesis that an amino acid change at position 9 alters the
quaternary structure of LGALS-11, we first estimated the sedi-
mentation velocities of recombinant isoforms 1 and 2. The c(s)
distributions (Fig. 3) at concentrations of 0.10, 0.30 and 0.90 mg/
ml showed that isoform 1 is represented by a tetramer at all
concentrations tested (sedimentation coefficient: 4.0 S), whereas
isoform 2 is in a monomer–dimer equilibrium (sedimentation
coefficients: 1.64 S and 2.5 S, respectively; Supplementary
Table 1). To verify the tetrameric organisation of isoform 1, we
then mutated residues L9 and S11 to alanine, produced a
recombinant dimerisation mutant (DI-m) protein and assessed
the sedimentation velocity of this protein. This DI-m protein
exists as a monomer–dimer equilibrium (sedimentation coeffi-
cients: 1.1 S (monomer) and 1.7 S (dimer), respectively), similar
to isoform 2 (Supplementary Table 1).
Effect of quaternary structure on biological function. To eval-
uate whether quaternary structure related to biological function, we
exposed exsheathed third-stage larvae (xL3s) of H. contortus to the
tetrameric isoform 1 or monomeric–dimeric isoform 2 (in solu-
tion) and assessed the effect of each isoform on the development of
xL3s to the fourth-stage larvae (L4s) of H. contortus. In an initial
experiment, galectin isoforms were tested at different doses
between 0.009 and 2.5 mg/ml, and doses >0.75mg/ml were shown
to have biological effects after 24 h incubation. Hence further
bioassays were tested at 1.0 mg/ml concentration of galectins. Most
xL3s (85%) exposed to isoform 1 did not develop to L4s, whereas
those exposed to isoform 2 developed normally (Fig. 4a). The
incubation of (in vitro-raised) L4s with isoform 1 for 72 h repro-
ducibly induced pronounced cuticular damage, a shrunken soma
and an accumulation of internal granules in ≥95% of larvae, ulti-
mately leading to larval destruction (Fig. 4b). By contrast, incu-
bation of L4s with isoform 2 resulted in very limited internal or
cuticular damage in <10% of larvae after 72 h (Fig. 4b).
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Discussion
Here, we revealed the structure of LGALS-11 and showed that
particular, single amino acid changes in this galectin can sub-
stantially alter this molecule’s oligomeric assembly and its inter-
action with a parasitic worm (H. contortus) in vitro under well-
controlled conditions. The findings from this investigation are
likely to have important implications for understanding the
fundamental molecular mechanisms of galectin-mediated parasite
cytotoxicity.
The LGALS-11 crystal structure enabled the localisation of the
precise residue variation in the dimer interface connecting β-
strands of two monomers, the glycan-binding groove and the
putative integrin-binding site. The residue substitution from a
hydrophobic residue (leucine) in isoform 1 to a polar or charged
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residue (glutamine) in isoform 2 is likely to hinder dimer for-
mation, and energetically favour contact with water rather than
the complementary polar (serine) residue (S11) to form a
homodimer. Through sedimentation velocity studies, we con-
firmed that the residue substitution in the dimer interface affects
the homodimers and subsequent oligomerisation of LGALS-11.
Dimerisation of prototype galectins (as is LGALS-11) are reported
to be critical for their function; for example, the dimeric form of
galectin-1 induces cell death (apoptosis), whereas the monomeric
form does not26,27. As the quaternary structure and oxidation
status of galectins alter ligand-binding and cross-linking
properties21,28,29, modulation of LGALS-11 dimerisation might
obviate galectin–glycan lattice formation and glycan preference of
isoform 2.
In contrast to most galectins that are constitutively expressed
and have multiple biological functions, the expression of LGALS-
11 in the gut epithelium appears only to be induced by parasites
and pregnancy15,16,30–33. This information suggests a specific role
of this molecule in these pathological and physiological processes.
Studies of the protective immune response against H. contortus
have shown secretion of LGALS-11 in stomach (abomasal) mucus
around the time that L3s moult to L4s, with LGALS-11 levels
remaining elevated during infection with the adult stage of the
pathogen33. Subsequent studies9,17 showed that LGALS-11 could
remarkably interfere with the moulting process to L4, and with
the growth of this stage. The transition of L3s to L4s requires
structural development facilitated by secretory processes34,35 and
takes place in the crypts of the abomasum, where the L4s are in
close contact with the epithelial cells that are known to secrete
LGALS-1115. Parasite stages, recovered in vivo from the aboma-
sum of infected sheep, were found to be already covered with
native galectin-119. Viability loss and death of larvae in vivo were
also associated with appearance of vacuoles and the cuticles
shrunken away from their sheaths 34,36. We have replicated these
in vivo observations, with our in vitro studies and suggest that the
mechanisms identified with recombinant galectin-11 in vitro can
occur in vivo. In addition, we demonstrated that only the
homotetrameric form of LGALS-11 inhibits H. contortus larval
development, and causes direct damage to the surface of the L4,
an indication of loss of viability and death36. No anti-parasitic
activity was detected for isoform 2 or the dimerisation interface
(DI-m) or carbohydrate recognition (CRD-m) mutant, indicating
that extended oligomerisation or lattice formation via self-
dimerisation and glycan recognition properties is critical for the
anti-parasitic effect. Lattice formation by lectins is reported to be
responsible for trapping and killing of free-living nematodes by
nematophagous fungi13,26,37, and a similar mechanism might be
involved here.
Variable genetic resistance to H. contortus and related worms,
both within and between breeds, is well known38,39, but the
molecular basis for this variation has not yet been established38,40.
The discovery of at least two natural isoforms of LGALS-11 and
their distinctly different anti-parasitic activities encourage future
work to explore whether each indeed confers anti-parasite resis-
tance or susceptibility. This could be done, for example, by
conducting a large-scale study of allelic variation in LGALS-11 in
populations of H. contortus-resistant and H. contortus-susceptible
sheep38, to test the hypothesis that quaternary structure of
LGALS-11, determined by an alteration at position 9, confers
natural resistance in sheep against H. contortus. Establishing an
unequivocal link with resistance or susceptibility could aid the
selective breeding of sheep for resistance to parasites, achieving
natural parasite control, and circumventing substantial problems
associated with anthelmintic resistance in H. contortus and rela-
ted parasites41. To the best of our knowledge, for the first time
this study demonstrates, the presence of two genetic variants of
LGALS-11 and demonstrates that the oligomeric property of this
galectin is critical for its anti-parasitic activity. Further studies are
needed to explore whether such gene variation plays a critical role
in the relative resistance of the host to parasite infection.
Methods
Molecular cloning of LGALS-11. The cDNAs encoding LGALS-11 were PCR
amplified from RNAs extracted from the stomach (abomasum) walls from 8–12-
Fig. 1 The crystal structure of LGALS-11. a Structure-based sequence alignment of LGALS-11 natural isoforms. Conserved residues are indicated by white
letters with black background, the dissimilar amino acids are indicated by black letters on a white background. The dimer interface is indicated by the black
triangles (residue 9 L/Q). An amino acid difference in the putative integrin-binding site is denoted by the grey triangle (residue 124 D/V). Carbohydrate-
recognising residues are indicated by blue asterisks. The secondary structures are indicated as beta (β) sheets with horizontal black arrows, turns with TT
letters and helices with squiggles. b The crystal structure of LGALS-11, and residues involved in cell attachment. The dimer interface between monomers at
residues L9 and S11 of the S1 β-strand via hydrogen bonds in a ball-and-stick representation; β-strands are labelled as S1–S6 and F1–F5 in both monomers (i).
Predicted cell attachment residues (L123, D124, V125, R126, G127 and D128) of LGALS-11 in a ball-and-stick representation within the rectangle (red dashed
line) (ii). c Residues in LGALS-11 are involved in glycan recognition. The residues R53, N64 and E74 of LGALS-11 make direct contact with β-D-galactose via
hydrogen bonding (green dashes), and V62 and W71 make non-bonded contact. Image produced using PDBsum server (https://www.ebi.ac.uk/pdbsum/).
Table 1 Data collection and refinement statistics of galectin-
11 protein crystals.
Gal11 (apo) Gal11 (complex)
Data collection
Space group P212121 P212121
Cell dimensions
a, b, c (Å) 96.17, 127.45, 141.41 96.11, 127.43, 140.33
α, β, γ (°) 90, 90, 90 90, 90, 90
Resolution (Å) 38.38–2.00 47.17–2.40
Rmerge 0.20 (1.04) 0.27 (1.27)
I/σI 6.6 (1.9) 7.3 (1.8)
Completeness (%) 98.6 (95.4) 99.4 (98.5)
Multiplicity 7.9 (6.4) 6.7 (6.4)
Refinement
Resolution (Å) 33.38–2.0
(2.07–2.0)
43.91–2.397
(2.48–2.39)
Total no. reflections 915,448 (35,018) 312,511 (28,539)
Total no. unique 115,747 (11,080) 68,269 (6720)
Rwork/Rfree (%) 19.2/23.8 16.04/20.91
No. atoms
Protein 8482 8519
Ligand/ion 30 60
Water 1478 1063
B-factors 16.26 22.26
R.M.S. deviations
Bond lengths (Å) 0.007 0.007
Bond angles (°) 0.96 0.89
Ramachandran plot (%)
Favoured 98.48 97.94
Allowed region 1.33 2.06
Disallowed region 0.19 0.00
Each data was collected from a single crystal.
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Fig. 2 Visualisation of surface hydrophobicity, and electrostatic properties of the LGALS-11 complex with β-D-galactose. Amino acid substitution in a
surface representation of hydrophobicity (a, b) and electrostatic properties (c, d) of residues in isoforms 1 and 2 of LGALS-11 are labelled with a one letter
code and position. The glycan-binding groove is highlighted and defined by dotted lines. The hydrophobicity properties of amino acids are indicated using
the Kyte and Doolittle hydrophobicity scale; the most polar residues are in medium purple and the most hydrophobic residues are in tan in the surface
representation. The electrostatic potential ranges from negative (red) to positive (blue). The surface properties of isoform 2 was derived by mutating the
residues in the crystal structure of isoform 1 to isoform 2, using the COOT tool. The hydrophobicity and Coulombic electrostatic potential of both isoforms
1 and 2 were displayed using the surface colouring feature of the UCSF Chimera tool (v.1.10.2).
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month old Merino sheep (O. aries; n= 16) with mixed sex, and cloned into a
modified pET-28 vector (m-pET-28) using an established method20. Clones
representing all 16 individual animals were directly sequenced, and insert
sequences verified by direct Sanger sequencing42. The similarity and secondary
structures of sequences were inferred using the online tool ESPript-3.0 (ref. 43). The
LGALS-11 sequences (accession nos. MH069213 and MH069214) representing
isoforms 1 and 2, respectively, were deposited in the NCBI database.
Mutagenesis. The cDNAs of two synthetic mutants of LGALS-11 were con-
structed (Bioneer Pacific, Australia). For mutant 1 (mutation in dimer interface
designated as (DI-m)), an alanine was substituted for each of the leucine or glu-
tamine (Q/L9A), and serine (S11 A) residues in the dimer interface domain
(Fig. 1a). For mutant 2 (mutation in CRD designated as CRD-m), an alanine was
substituted for each of the residues P51A, R53A, W55A, V62A, N64A, W71AE74A
and K76A in the carbohydrate-recognising domain (Fig. 1a). Each of the two
cDNAs was cloned into m-pET-28 using a ligation-independent approach44, and
insert sequences verified by direct sequencing42.
Recombinant expression and purification LGALS-11 isoforms. Recombinant
LGALS-11 isoforms 1 and 2, as well as the mutants DI-m and CRD-m were each
expressed in Escherichia coli strain BL21 (DE3), purified using established meth-
ods20 and stored at −80 °C until use.
Measuring sedimentation velocity. LGALS-11 isoforms 1 and 2 (0.10, 0.30 and
0.90 mg/ml) were each dissolved in Tris buffer (20 mM Tris-HCL pH 8.0, 100 mM
NaCl, 0.5 mM TCEP pH 8.0) and their sedimentation velocities established using
analytical ultracentrifuge (model XL-I, Beckman), equipped with a photoelectric
optical absorbance system. Protein (380 μl) and reference (400 μl) samples were
Fig. 3 Sedimentation velocity analysis of LGALS-11 isoforms 1 and 2. The continuous sedimentation coefficient [c(s)] distribution is plotted as a function
of the standardised sedimentation coefficient at 0.10, 0.30 and 0.90mg/ml, as indicated. Continuous size-distribution analysis was performed using the
programme SEDFIT at a resolution of 200, with Smin= 0.5 S, Smax = 10 S, at a P-value of 0.95 for isoforms 1 and 2. Data are representative of three
replicates.
Fig. 4 Anti-parasitic activity of LGALS-11 isoforms on H. contortus. a The effect of LGALS-11 isoform 1 on H. contortus larval development. Exsheathed
larval stages (xL3s) were incubated with LGALS-11 isoform 1 or 2, or carbohydrate recognition domain mutant (CRD-m) or dimer interface mutant (DI-m)
for 7 days at 0.009–2.5 mg/ml concentration. L4 development was recorded microscopically. Control larvae were incubated for the same time only in the
buffer used to resuspend individual LGALS-11 proteins. b Pathological changes observed in the L4 stage of H. contortus incubated with LGALS-11 isoform 1.
Images showing representative phenotypes of L4 larvae following incubation with LGALS-11 isoform 1 or 2, or mutant CRD-m or DI-m for 3 days (1 mg/ml);
control larvae were incubated for the same time only in the buffer used to resuspend individual LGALS-11 proteins. Extensive structural damage was
observed in larvae incubated with isoform 1 at 1 mg/ml concentration. Scale bar= 20 μm.
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loaded into a conventional double-sector quartz cell, mounted in a Beckman An-60
Ti rotor and centrifuged at 120,000 × g at 20 °C. Data were collected at 280 nm in
the continuous mode using a step size of 0.003 cm. Solvent density (1.00498 g/ml at
20 °C) and viscosity (1.002 cp at 20 °C), and estimates of the partial specific volume,
V_(0.744815 ml/g and 0.74269 ml/mg for isoforms 1 and 2, respectively, at 20 °C),
were computed using the programme SEDNTERP45. Sedimentation velocity data
at multiple time points were fitted to a continuous size-distribution model46–48
using the programme SEDFIT47. The three independent experiments were
performed.
Crystallisation and X-ray diffraction analysis. Recombinant LGALS-11 protein
was purified, crystallised and diffraction data collected in Australian synchrotron as
described20. The data were processed with MOSFLM and scaled using the pro-
gramme AIMLESS of the CCP4 program suite. The initial phases for LGALS-11
were obtained by PHASER using the coordinates of human galectin-10 (Charcot-
Leyden crystal protein; PDB code: 1QKQ)49. Crystallographic refinement was done
using PHENIX50, and modelling was conducted using COOT v. 8.0 (ref. 51). The
PDB structure coordinates were validated using MOLPROBITY52, and crystal-
lographic images were drawn using PYMOL and UCSF chimera. The atomic
coordinates and observed structural factors have been deposited (under codes
6N3R and 6N44, respectively) in the Research Collaboratory for Structural
Bioinformatics PDB.
Bioassay. A well-established bioassay for H. contortus was used9. In this assay,
each recombinant isoform (n= 2) and mutant (n= 2) of LGALS-11 was tested (in
triplicate) on xL3 and L4 stages, using an irrelevant protein and Tris buffer (pH
7.4) as controls. This was done by adding individual recombinant proteins in Tris
buffer (50 µl) at a serial concentration of 0.009 to 2.5 mg/ml (two steps) to wells
each containing 300 xL3s or L4s in DMEM (pH 7.4), and incubated at 37 °C and
10% (v/v) CO2. The motility of xL3s in individual wells was measured after 72 h,
and the growth, development and morphology of L4s were assessed after 7 days.
Ethics approval and consent to participate. Handling of animals and experi-
mental procedures were approved by the Monash University Animal Ethics
Committee (Ethics # SOBSA/P/2009/44).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The information supporting the conclusions of this article is included in the article. The
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